Automated blood collection market seen reaching $3.46 billion by 2030

A new report from The Business Research Company says the automated blood collection market is expanding quickly, with growth tied to robotics, point-of-care testing and hospital automation. North America led the market in 2025, while rising blood donations worldwide continue to support demand.

Why it matters: - Automated blood collection is designed to make blood sampling faster, more accurate and less dependent on manual labor. - The shift could improve patient comfort and safety while reducing errors in labs, hospitals and donation settings. - The market’s growth reflects broader demand for automation across healthcare operations.

What happened: - The Business Research Company released a report on the global automated blood collection market on July 27, 2026. - The report valued the market at $1.52 billion in 2025 and projected $1.8 billion in 2026. - The report forecasts the market will reach $3.46 billion by 2030. - North America held the largest regional share in 2025.

The details: - The report said the market grew in the historical period because manual blood collection remains common, automated systems are still limited in availability and diagnostic and hospital procedures have increased. - The report also pointed to rising demand for precise diagnostic results as a growth driver. - Looking ahead, the report linked future growth to robotic venipuncture technology, point-of-care testing, hospital automation, expansion of diagnostic and pathology labs and supportive regulations for automated sampling. - The report projected a 18.1% CAGR in 2026 and a 17.7% CAGR through 2030. - The regional analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspot infographics and updated graphics and tables. - The report offers a free sample and full report.

Between the lines: - The report frames automation as part of a broader push to reduce friction in clinical workflows, not just a niche equipment upgrade. - Rising blood donations give the market a practical demand base beyond hospital efficiency alone. - North America’s lead suggests established healthcare infrastructure may be accelerating adoption first.

What's next: - The report expects stronger adoption as healthcare systems invest more in automation and point-of-care testing. - Diagnostic labs, pathology labs and hospital networks are likely to remain the main end markets as the technology matures. - The market’s trajectory will depend on how quickly automated sampling moves from a specialized option to a standard workflow tool.

The bottom line: - Automated blood collection is moving from emerging technology to a fast-growing healthcare automation category, with the market expected to more than double by 2030.